These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1062 related articles for article (PubMed ID: 33945007)

  • 1. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis.
    Gosavi R; Chia C; Michael M; Heriot AG; Warrier SK; Kong JC
    Int J Colorectal Dis; 2021 Oct; 36(10):2063-2070. PubMed ID: 33945007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.
    Hu H; Zhang J; Li Y; Wang X; Wang Z; Wang H; Kang L; Liu P; Lan P; Wu X; Zhen Y; Pei H; Huang Z; Zhang H; Chen W; Zeng Y; Lai J; Wei H; Huang X; Chen J; Chen J; Tao K; Xu Q; Peng X; Liang J; Cai G; Ding K; Ding Z; Hu M; Zhang W; Tang B; Hong C; Cao J; Huang Z; Cao W; Li F; Wang X; Wang C; Huang Y; Zhao Y; Cai Y; Ling J; Xie X; Wu Z; Shi L; Ling L; Liu H; Wang J; Huang M; Deng Y;
    J Clin Oncol; 2024 Sep; 42(25):2978-2988. PubMed ID: 38564700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review.
    Arredondo J; Pastor E; Simó V; Beltrán M; Castañón C; Magdaleno MC; Matanza I; Notarnicola M; Ielpo B
    Tech Coloproctol; 2020 Oct; 24(10):1001-1015. PubMed ID: 32666362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis.
    Zeng W; Liu Y; Wang C; Yang C; Lin S; Li W
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the oncological safety of neoadjuvant chemotherapy in locally advanced colon carcinoma: a systematic review and meta-analysis of randomised clinical trials and propensity-matched studies.
    Davey MG; Amir AH; Ryan OK; Donnelly M; Donlon NE; Regan M; Meshkat B; Nugent E; Joyce M; Hogan AM
    Int J Colorectal Dis; 2023 Jul; 38(1):193. PubMed ID: 37432559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Evidence for the Benefits of Neoadjuvant Chemotherapy and Immunotherapy in Colon Cancer: A Concise Review.
    Gupta K; Elfiky A; Patel E
    Discov Med; 2023 Dec; 35(179):928-935. PubMed ID: 38058057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
    Ebata Y; Nakanishi R; Tanaka Y; Kawazoe T; Tajiri H; Zaitsu Y; Nakashima Y; Ota M; Oki E; Yoshizumi T
    Anticancer Res; 2024 Mar; 44(3):1281-1287. PubMed ID: 38423645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
    Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
    World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial.
    Foxtrot Collaborative Group
    Lancet Oncol; 2012 Nov; 13(11):1152-60. PubMed ID: 23017669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalizing neoadjuvant chemotherapy for locally advanced colon cancer: protocols for the international phase III FOxTROT2 and FOxTROT3 randomized controlled trials.
    Platt JR; Williams CJM; Craig Z; Cairns DA; Glasbey JC; Morton D; Seligmann J
    Colorectal Dis; 2023 Mar; 25(3):357-366. PubMed ID: 36710525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant FOLFOX chemotherapy combined with radiotherapy followed by radical resection in patients with locally advanced colon cancer.
    Huang CM; Huang MY; Ma CJ; Yeh Y-; Tsai HL; Huang CW; Huang CJ; Wang JY
    Radiat Oncol; 2017 Mar; 12(1):48. PubMed ID: 28270172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection.
    Yuan Y; Xiao WW; Xie WH; Cai PQ; Wang QX; Chang H; Chen BQ; Zhou WH; Zeng ZF; Wu XJ; Liu Q; Li LR; Zhang R; Gao YH
    BMC Cancer; 2021 Feb; 21(1):179. PubMed ID: 33607964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.
    Aliseda D; Arredondo J; Sánchez-Justicia C; Alvarellos A; Rodríguez J; Matos I; Rotellar F; Baixauli J; Pastor C
    Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38381934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.
    Ueki T; Manabe T; Inoue S; Ienaga J; Yamanaka N; Egami T; Ishikawa M; Konomi H; Ikubo A; Nagayoshi K; Nakamura M; Tanaka M
    Anticancer Res; 2016 Feb; 36(2):741-7. PubMed ID: 26851033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.
    Morton D; Seymour M; Magill L; Handley K; Glasbey J; Glimelius B; Palmer A; Seligmann J; Laurberg S; Murakami K; West N; Quirke P; Gray R;
    J Clin Oncol; 2023 Mar; 41(8):1541-1552. PubMed ID: 36657089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22).
    Karoui M; Rullier A; Piessen G; Legoux JL; Barbier E; De Chaisemartin C; Lecaille C; Bouche O; Ammarguellat H; Brunetti F; Prudhomme M; Regimbeau JM; Glehen O; Lievre A; Portier G; Hartwig J; Goujon G; Romain B; Lepage C; Taieb J;
    Ann Surg; 2020 Apr; 271(4):637-645. PubMed ID: 31356278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
    Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
    Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial.
    Liu F; Tong T; Huang D; Yuan W; Li D; Lin J; Cai S; Xu Y; Chen W; Sun Y; Zhuang J
    BMJ Open; 2019 Jan; 9(1):e017637. PubMed ID: 30700474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.